Global Radiopharmaceutical (Oral Route) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Radiopharmaceutical (Oral Route) Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical (Oral Route) sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical (Oral Route) sales for 2023 through 2029. With Radiopharmaceutical (Oral Route) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical (Oral Route) industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical (Oral Route) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical (Oral Route) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radiopharmaceutical (Oral Route) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical (Oral Route) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical (Oral Route).
The global Radiopharmaceutical (Oral Route) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiopharmaceutical (Oral Route) players cover Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Radiopharmaceutical (Oral Route) market?
What factors are driving Radiopharmaceutical (Oral Route) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical (Oral Route) market opportunities vary by end market size?
How does Radiopharmaceutical (Oral Route) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Radiopharmaceutical (Oral Route) Industry Forecast” looks at past sales and reviews total world Radiopharmaceutical (Oral Route) sales in 2022, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical (Oral Route) sales for 2023 through 2029. With Radiopharmaceutical (Oral Route) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical (Oral Route) industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical (Oral Route) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Radiopharmaceutical (Oral Route) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Radiopharmaceutical (Oral Route) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical (Oral Route) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical (Oral Route).
The global Radiopharmaceutical (Oral Route) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Radiopharmaceutical (Oral Route) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Radiopharmaceutical (Oral Route) players cover Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare and China Isotope & Radiation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Actinium-225
- Lutetium-177
- Radium-223
- Holmium-166
- Other
- Oncology
- Cardiology
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bracco Imaging
- Bayer
- Mallinckrodt
- Nordion
- Triad Isotopes
- Lantheus
- IBA Group
- GE Healthcare
- China Isotope & Radiation
- Jubilant Pharma
- Eli Lilly
- Advanced Accelerator Applications
- SIEMENS
- Dongcheng
- Navidea
What is the 10-year outlook for the global Radiopharmaceutical (Oral Route) market?
What factors are driving Radiopharmaceutical (Oral Route) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Radiopharmaceutical (Oral Route) market opportunities vary by end market size?
How does Radiopharmaceutical (Oral Route) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Country/Region, 2018, 2022 & 2029
2.2 Radiopharmaceutical (Oral Route) Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical (Oral Route) Sales by Type
2.3.1 Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
2.3.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Type (2018-2023)
2.4 Radiopharmaceutical (Oral Route) Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical (Oral Route) Sales by Application
2.5.1 Global Radiopharmaceutical (Oral Route) Sale Market Share by Application (2018-2023)
2.5.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Radiopharmaceutical (Oral Route) Sale Price by Application (2018-2023)
3 GLOBAL RADIOPHARMACEUTICAL (ORAL ROUTE) BY COMPANY
3.1 Global Radiopharmaceutical (Oral Route) Breakdown Data by Company
3.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Company (2018-2023)
3.1.2 Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2018-2023)
3.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Company (2018-2023)
3.2.1 Global Radiopharmaceutical (Oral Route) Revenue by Company (2018-2023)
3.2.2 Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2018-2023)
3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical (Oral Route) Product Location Distribution
3.4.2 Players Radiopharmaceutical (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL (ORAL ROUTE) BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical (Oral Route) Market Size by Geographic Region (2018-2023)
4.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radiopharmaceutical (Oral Route) Market Size by Country/Region (2018-2023)
4.2.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radiopharmaceutical (Oral Route) Sales Growth
4.4 APAC Radiopharmaceutical (Oral Route) Sales Growth
4.5 Europe Radiopharmaceutical (Oral Route) Sales Growth
4.6 Middle East & Africa Radiopharmaceutical (Oral Route) Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical (Oral Route) Sales by Country
5.1.1 Americas Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
5.1.2 Americas Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
5.2 Americas Radiopharmaceutical (Oral Route) Sales by Type
5.3 Americas Radiopharmaceutical (Oral Route) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical (Oral Route) Sales by Region
6.1.1 APAC Radiopharmaceutical (Oral Route) Sales by Region (2018-2023)
6.1.2 APAC Radiopharmaceutical (Oral Route) Revenue by Region (2018-2023)
6.2 APAC Radiopharmaceutical (Oral Route) Sales by Type
6.3 APAC Radiopharmaceutical (Oral Route) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical (Oral Route) by Country
7.1.1 Europe Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
7.1.2 Europe Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
7.2 Europe Radiopharmaceutical (Oral Route) Sales by Type
7.3 Europe Radiopharmaceutical (Oral Route) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical (Oral Route) by Country
8.1.1 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
8.2 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type
8.3 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route)
10.3 Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
10.4 Industry Chain Structure of Radiopharmaceutical (Oral Route)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical (Oral Route) Distributors
11.3 Radiopharmaceutical (Oral Route) Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL (ORAL ROUTE) BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical (Oral Route) Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical (Oral Route) Forecast by Region (2024-2029)
12.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceutical (Oral Route) Forecast by Type
12.7 Global Radiopharmaceutical (Oral Route) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.2.3 Bayer Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.4.3 Nordion Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.6.3 Lantheus Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.7.3 IBA Group Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.13.3 SIEMENS Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.15.3 Navidea Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Radiopharmaceutical (Oral Route) by Country/Region, 2018, 2022 & 2029
2.2 Radiopharmaceutical (Oral Route) Segment by Type
2.2.1 Actinium-225
2.2.2 Lutetium-177
2.2.3 Radium-223
2.2.4 Holmium-166
2.2.5 Other
2.3 Radiopharmaceutical (Oral Route) Sales by Type
2.3.1 Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
2.3.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Type (2018-2023)
2.4 Radiopharmaceutical (Oral Route) Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceutical (Oral Route) Sales by Application
2.5.1 Global Radiopharmaceutical (Oral Route) Sale Market Share by Application (2018-2023)
2.5.2 Global Radiopharmaceutical (Oral Route) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Radiopharmaceutical (Oral Route) Sale Price by Application (2018-2023)
3 GLOBAL RADIOPHARMACEUTICAL (ORAL ROUTE) BY COMPANY
3.1 Global Radiopharmaceutical (Oral Route) Breakdown Data by Company
3.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Company (2018-2023)
3.1.2 Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2018-2023)
3.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Company (2018-2023)
3.2.1 Global Radiopharmaceutical (Oral Route) Revenue by Company (2018-2023)
3.2.2 Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2018-2023)
3.3 Global Radiopharmaceutical (Oral Route) Sale Price by Company
3.4 Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Radiopharmaceutical (Oral Route) Product Location Distribution
3.4.2 Players Radiopharmaceutical (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RADIOPHARMACEUTICAL (ORAL ROUTE) BY GEOGRAPHIC REGION
4.1 World Historic Radiopharmaceutical (Oral Route) Market Size by Geographic Region (2018-2023)
4.1.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Radiopharmaceutical (Oral Route) Market Size by Country/Region (2018-2023)
4.2.1 Global Radiopharmaceutical (Oral Route) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Radiopharmaceutical (Oral Route) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Radiopharmaceutical (Oral Route) Sales Growth
4.4 APAC Radiopharmaceutical (Oral Route) Sales Growth
4.5 Europe Radiopharmaceutical (Oral Route) Sales Growth
4.6 Middle East & Africa Radiopharmaceutical (Oral Route) Sales Growth
5 AMERICAS
5.1 Americas Radiopharmaceutical (Oral Route) Sales by Country
5.1.1 Americas Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
5.1.2 Americas Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
5.2 Americas Radiopharmaceutical (Oral Route) Sales by Type
5.3 Americas Radiopharmaceutical (Oral Route) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical (Oral Route) Sales by Region
6.1.1 APAC Radiopharmaceutical (Oral Route) Sales by Region (2018-2023)
6.1.2 APAC Radiopharmaceutical (Oral Route) Revenue by Region (2018-2023)
6.2 APAC Radiopharmaceutical (Oral Route) Sales by Type
6.3 APAC Radiopharmaceutical (Oral Route) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Radiopharmaceutical (Oral Route) by Country
7.1.1 Europe Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
7.1.2 Europe Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
7.2 Europe Radiopharmaceutical (Oral Route) Sales by Type
7.3 Europe Radiopharmaceutical (Oral Route) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical (Oral Route) by Country
8.1.1 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023)
8.2 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type
8.3 Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route)
10.3 Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
10.4 Industry Chain Structure of Radiopharmaceutical (Oral Route)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Radiopharmaceutical (Oral Route) Distributors
11.3 Radiopharmaceutical (Oral Route) Customer
12 WORLD FORECAST REVIEW FOR RADIOPHARMACEUTICAL (ORAL ROUTE) BY GEOGRAPHIC REGION
12.1 Global Radiopharmaceutical (Oral Route) Market Size Forecast by Region
12.1.1 Global Radiopharmaceutical (Oral Route) Forecast by Region (2024-2029)
12.1.2 Global Radiopharmaceutical (Oral Route) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Radiopharmaceutical (Oral Route) Forecast by Type
12.7 Global Radiopharmaceutical (Oral Route) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bracco Imaging
13.1.1 Bracco Imaging Company Information
13.1.2 Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.1.3 Bracco Imaging Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bracco Imaging Main Business Overview
13.1.5 Bracco Imaging Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.2.3 Bayer Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.3.3 Mallinckrodt Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Nordion
13.4.1 Nordion Company Information
13.4.2 Nordion Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.4.3 Nordion Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nordion Main Business Overview
13.4.5 Nordion Latest Developments
13.5 Triad Isotopes
13.5.1 Triad Isotopes Company Information
13.5.2 Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.5.3 Triad Isotopes Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Triad Isotopes Main Business Overview
13.5.5 Triad Isotopes Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.6.3 Lantheus Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 IBA Group
13.7.1 IBA Group Company Information
13.7.2 IBA Group Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.7.3 IBA Group Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 IBA Group Main Business Overview
13.7.5 IBA Group Latest Developments
13.8 GE Healthcare
13.8.1 GE Healthcare Company Information
13.8.2 GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.8.3 GE Healthcare Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 GE Healthcare Main Business Overview
13.8.5 GE Healthcare Latest Developments
13.9 China Isotope & Radiation
13.9.1 China Isotope & Radiation Company Information
13.9.2 China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.9.3 China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China Isotope & Radiation Main Business Overview
13.9.5 China Isotope & Radiation Latest Developments
13.10 Jubilant Pharma
13.10.1 Jubilant Pharma Company Information
13.10.2 Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.10.3 Jubilant Pharma Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Jubilant Pharma Main Business Overview
13.10.5 Jubilant Pharma Latest Developments
13.11 Eli Lilly
13.11.1 Eli Lilly Company Information
13.11.2 Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.11.3 Eli Lilly Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Eli Lilly Main Business Overview
13.11.5 Eli Lilly Latest Developments
13.12 Advanced Accelerator Applications
13.12.1 Advanced Accelerator Applications Company Information
13.12.2 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.12.3 Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Advanced Accelerator Applications Main Business Overview
13.12.5 Advanced Accelerator Applications Latest Developments
13.13 SIEMENS
13.13.1 SIEMENS Company Information
13.13.2 SIEMENS Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.13.3 SIEMENS Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 SIEMENS Main Business Overview
13.13.5 SIEMENS Latest Developments
13.14 Dongcheng
13.14.1 Dongcheng Company Information
13.14.2 Dongcheng Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.14.3 Dongcheng Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Dongcheng Main Business Overview
13.14.5 Dongcheng Latest Developments
13.15 Navidea
13.15.1 Navidea Company Information
13.15.2 Navidea Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
13.15.3 Navidea Radiopharmaceutical (Oral Route) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Navidea Main Business Overview
13.15.5 Navidea Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Radium-223
Table 6. Major Players of Holmium-166
Table 7. Major Players of Other
Table 8. Global Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 9. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Table 10. Global Radiopharmaceutical (Oral Route) Revenue by Type (2018-2023) & ($ million)
Table 11. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2018-2023)
Table 12. Global Radiopharmaceutical (Oral Route) Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Table 15. Global Radiopharmaceutical (Oral Route) Revenue by Application (2018-2023)
Table 16. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application (2018-2023)
Table 17. Global Radiopharmaceutical (Oral Route) Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Radiopharmaceutical (Oral Route) Sales by Company (2018-2023) & (K Units)
Table 19. Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2018-2023)
Table 20. Global Radiopharmaceutical (Oral Route) Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2018-2023)
Table 22. Global Radiopharmaceutical (Oral Route) Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution and Sales Area
Table 24. Players Radiopharmaceutical (Oral Route) Products Offered
Table 25. Radiopharmaceutical (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Radiopharmaceutical (Oral Route) Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Radiopharmaceutical (Oral Route) Sales Market Share Geographic Region (2018-2023)
Table 30. Global Radiopharmaceutical (Oral Route) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Radiopharmaceutical (Oral Route) Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Radiopharmaceutical (Oral Route) Sales Market Share by Country/Region (2018-2023)
Table 34. Global Radiopharmaceutical (Oral Route) Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 37. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 38. Americas Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 40. Americas Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 41. Americas Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 42. APAC Radiopharmaceutical (Oral Route) Sales by Region (2018-2023) & (K Units)
Table 43. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region (2018-2023)
Table 44. APAC Radiopharmaceutical (Oral Route) Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Region (2018-2023)
Table 46. APAC Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 47. APAC Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 48. Europe Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 49. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 50. Europe Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 52. Europe Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 53. Europe Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Radiopharmaceutical (Oral Route)
Table 61. Key Market Challenges & Risks of Radiopharmaceutical (Oral Route)
Table 62. Key Industry Trends of Radiopharmaceutical (Oral Route)
Table 63. Radiopharmaceutical (Oral Route) Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Radiopharmaceutical (Oral Route) Distributors List
Table 66. Radiopharmaceutical (Oral Route) Customer List
Table 67. Global Radiopharmaceutical (Oral Route) Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Radiopharmaceutical (Oral Route) Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Radiopharmaceutical (Oral Route) Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Radiopharmaceutical (Oral Route) Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Bracco Imaging Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 83. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Bracco Imaging Main Business
Table 85. Bracco Imaging Latest Developments
Table 86. Bayer Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 88. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Mallinckrodt Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 93. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Nordion Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 97. Nordion Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 98. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Nordion Main Business
Table 100. Nordion Latest Developments
Table 101. Triad Isotopes Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 102. Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 103. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Triad Isotopes Main Business
Table 105. Triad Isotopes Latest Developments
Table 106. Lantheus Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 107. Lantheus Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 108. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Lantheus Main Business
Table 110. Lantheus Latest Developments
Table 111. IBA Group Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 112. IBA Group Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 113. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. IBA Group Main Business
Table 115. IBA Group Latest Developments
Table 116. GE Healthcare Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 118. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. China Isotope & Radiation Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 122. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 123. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. China Isotope & Radiation Main Business
Table 125. China Isotope & Radiation Latest Developments
Table 126. Jubilant Pharma Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 127. Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 128. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Jubilant Pharma Main Business
Table 130. Jubilant Pharma Latest Developments
Table 131. Eli Lilly Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 133. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Eli Lilly Main Business
Table 135. Eli Lilly Latest Developments
Table 136. Advanced Accelerator Applications Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 137. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 138. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Advanced Accelerator Applications Main Business
Table 140. Advanced Accelerator Applications Latest Developments
Table 141. SIEMENS Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 142. SIEMENS Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 143. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. SIEMENS Main Business
Table 145. SIEMENS Latest Developments
Table 146. Dongcheng Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 147. Dongcheng Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 148. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Dongcheng Main Business
Table 150. Dongcheng Latest Developments
Table 151. Navidea Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 152. Navidea Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 153. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Navidea Main Business
Table 155. Navidea Latest Developments
Table 1. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Radiopharmaceutical (Oral Route) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Actinium-225
Table 4. Major Players of Lutetium-177
Table 5. Major Players of Radium-223
Table 6. Major Players of Holmium-166
Table 7. Major Players of Other
Table 8. Global Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 9. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Table 10. Global Radiopharmaceutical (Oral Route) Revenue by Type (2018-2023) & ($ million)
Table 11. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2018-2023)
Table 12. Global Radiopharmaceutical (Oral Route) Sale Price by Type (2018-2023) & (US$/Unit)
Table 13. Global Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Table 15. Global Radiopharmaceutical (Oral Route) Revenue by Application (2018-2023)
Table 16. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application (2018-2023)
Table 17. Global Radiopharmaceutical (Oral Route) Sale Price by Application (2018-2023) & (US$/Unit)
Table 18. Global Radiopharmaceutical (Oral Route) Sales by Company (2018-2023) & (K Units)
Table 19. Global Radiopharmaceutical (Oral Route) Sales Market Share by Company (2018-2023)
Table 20. Global Radiopharmaceutical (Oral Route) Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company (2018-2023)
Table 22. Global Radiopharmaceutical (Oral Route) Sale Price by Company (2018-2023) & (US$/Unit)
Table 23. Key Manufacturers Radiopharmaceutical (Oral Route) Producing Area Distribution and Sales Area
Table 24. Players Radiopharmaceutical (Oral Route) Products Offered
Table 25. Radiopharmaceutical (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Radiopharmaceutical (Oral Route) Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Radiopharmaceutical (Oral Route) Sales Market Share Geographic Region (2018-2023)
Table 30. Global Radiopharmaceutical (Oral Route) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Radiopharmaceutical (Oral Route) Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Radiopharmaceutical (Oral Route) Sales Market Share by Country/Region (2018-2023)
Table 34. Global Radiopharmaceutical (Oral Route) Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 37. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 38. Americas Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 40. Americas Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 41. Americas Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 42. APAC Radiopharmaceutical (Oral Route) Sales by Region (2018-2023) & (K Units)
Table 43. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region (2018-2023)
Table 44. APAC Radiopharmaceutical (Oral Route) Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Region (2018-2023)
Table 46. APAC Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 47. APAC Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 48. Europe Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 49. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 50. Europe Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 52. Europe Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 53. Europe Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Radiopharmaceutical (Oral Route) Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Radiopharmaceutical (Oral Route)
Table 61. Key Market Challenges & Risks of Radiopharmaceutical (Oral Route)
Table 62. Key Industry Trends of Radiopharmaceutical (Oral Route)
Table 63. Radiopharmaceutical (Oral Route) Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Radiopharmaceutical (Oral Route) Distributors List
Table 66. Radiopharmaceutical (Oral Route) Customer List
Table 67. Global Radiopharmaceutical (Oral Route) Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Radiopharmaceutical (Oral Route) Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Radiopharmaceutical (Oral Route) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Radiopharmaceutical (Oral Route) Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Radiopharmaceutical (Oral Route) Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Radiopharmaceutical (Oral Route) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Bracco Imaging Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 82. Bracco Imaging Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 83. Bracco Imaging Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 84. Bracco Imaging Main Business
Table 85. Bracco Imaging Latest Developments
Table 86. Bayer Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 87. Bayer Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 88. Bayer Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 89. Bayer Main Business
Table 90. Bayer Latest Developments
Table 91. Mallinckrodt Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 92. Mallinckrodt Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 93. Mallinckrodt Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 94. Mallinckrodt Main Business
Table 95. Mallinckrodt Latest Developments
Table 96. Nordion Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 97. Nordion Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 98. Nordion Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 99. Nordion Main Business
Table 100. Nordion Latest Developments
Table 101. Triad Isotopes Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 102. Triad Isotopes Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 103. Triad Isotopes Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 104. Triad Isotopes Main Business
Table 105. Triad Isotopes Latest Developments
Table 106. Lantheus Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 107. Lantheus Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 108. Lantheus Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 109. Lantheus Main Business
Table 110. Lantheus Latest Developments
Table 111. IBA Group Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 112. IBA Group Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 113. IBA Group Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 114. IBA Group Main Business
Table 115. IBA Group Latest Developments
Table 116. GE Healthcare Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 117. GE Healthcare Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 118. GE Healthcare Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 119. GE Healthcare Main Business
Table 120. GE Healthcare Latest Developments
Table 121. China Isotope & Radiation Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 122. China Isotope & Radiation Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 123. China Isotope & Radiation Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 124. China Isotope & Radiation Main Business
Table 125. China Isotope & Radiation Latest Developments
Table 126. Jubilant Pharma Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 127. Jubilant Pharma Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 128. Jubilant Pharma Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 129. Jubilant Pharma Main Business
Table 130. Jubilant Pharma Latest Developments
Table 131. Eli Lilly Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 132. Eli Lilly Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 133. Eli Lilly Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 134. Eli Lilly Main Business
Table 135. Eli Lilly Latest Developments
Table 136. Advanced Accelerator Applications Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 137. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 138. Advanced Accelerator Applications Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 139. Advanced Accelerator Applications Main Business
Table 140. Advanced Accelerator Applications Latest Developments
Table 141. SIEMENS Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 142. SIEMENS Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 143. SIEMENS Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 144. SIEMENS Main Business
Table 145. SIEMENS Latest Developments
Table 146. Dongcheng Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 147. Dongcheng Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 148. Dongcheng Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 149. Dongcheng Main Business
Table 150. Dongcheng Latest Developments
Table 151. Navidea Basic Information, Radiopharmaceutical (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 152. Navidea Radiopharmaceutical (Oral Route) Product Portfolios and Specifications
Table 153. Navidea Radiopharmaceutical (Oral Route) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 154. Navidea Main Business
Table 155. Navidea Latest Developments
LIST OF FIGURES
Figure 1. Picture of Radiopharmaceutical (Oral Route)
Figure 2. Radiopharmaceutical (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical (Oral Route) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Radiopharmaceutical (Oral Route) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radiopharmaceutical (Oral Route) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Actinium-225
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Holmium-166
Figure 13. Product Picture of Other
Figure 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type in 2022
Figure 15. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2018-2023)
Figure 16. Radiopharmaceutical (Oral Route) Consumed in Oncology
Figure 17. Global Radiopharmaceutical (Oral Route) Market: Oncology (2018-2023) & (K Units)
Figure 18. Radiopharmaceutical (Oral Route) Consumed in Cardiology
Figure 19. Global Radiopharmaceutical (Oral Route) Market: Cardiology (2018-2023) & (K Units)
Figure 20. Radiopharmaceutical (Oral Route) Consumed in Other
Figure 21. Global Radiopharmaceutical (Oral Route) Market: Other (2018-2023) & (K Units)
Figure 22. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2022)
Figure 23. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application in 2022
Figure 24. Radiopharmaceutical (Oral Route) Sales Market by Company in 2022 (K Units)
Figure 25. Global Radiopharmaceutical (Oral Route) Sales Market Share by Company in 2022
Figure 26. Radiopharmaceutical (Oral Route) Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company in 2022
Figure 28. Global Radiopharmaceutical (Oral Route) Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 31. Americas Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 32. APAC Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 33. APAC Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 34. Europe Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 35. Europe Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 38. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 40. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 41. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 42. United States Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region in 2022
Figure 47. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Regions in 2022
Figure 48. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 49. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 50. China Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 58. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 59. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 60. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 61. Germany Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 70. Egypt Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route) in 2022
Figure 76. Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
Figure 77. Industry Chain Structure of Radiopharmaceutical (Oral Route)
Figure 78. Channels of Distribution
Figure 79. Global Radiopharmaceutical (Oral Route) Sales Market Forecast by Region (2024-2029)
Figure 80. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Radiopharmaceutical (Oral Route)
Figure 2. Radiopharmaceutical (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Radiopharmaceutical (Oral Route) Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Radiopharmaceutical (Oral Route) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Radiopharmaceutical (Oral Route) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Actinium-225
Figure 10. Product Picture of Lutetium-177
Figure 11. Product Picture of Radium-223
Figure 12. Product Picture of Holmium-166
Figure 13. Product Picture of Other
Figure 14. Global Radiopharmaceutical (Oral Route) Sales Market Share by Type in 2022
Figure 15. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Type (2018-2023)
Figure 16. Radiopharmaceutical (Oral Route) Consumed in Oncology
Figure 17. Global Radiopharmaceutical (Oral Route) Market: Oncology (2018-2023) & (K Units)
Figure 18. Radiopharmaceutical (Oral Route) Consumed in Cardiology
Figure 19. Global Radiopharmaceutical (Oral Route) Market: Cardiology (2018-2023) & (K Units)
Figure 20. Radiopharmaceutical (Oral Route) Consumed in Other
Figure 21. Global Radiopharmaceutical (Oral Route) Market: Other (2018-2023) & (K Units)
Figure 22. Global Radiopharmaceutical (Oral Route) Sales Market Share by Application (2022)
Figure 23. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Application in 2022
Figure 24. Radiopharmaceutical (Oral Route) Sales Market by Company in 2022 (K Units)
Figure 25. Global Radiopharmaceutical (Oral Route) Sales Market Share by Company in 2022
Figure 26. Radiopharmaceutical (Oral Route) Revenue Market by Company in 2022 ($ Million)
Figure 27. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Company in 2022
Figure 28. Global Radiopharmaceutical (Oral Route) Sales Market Share by Geographic Region (2018-2023)
Figure 29. Global Radiopharmaceutical (Oral Route) Revenue Market Share by Geographic Region in 2022
Figure 30. Americas Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 31. Americas Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 32. APAC Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 33. APAC Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 34. Europe Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 35. Europe Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 36. Middle East & Africa Radiopharmaceutical (Oral Route) Sales 2018-2023 (K Units)
Figure 37. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue 2018-2023 ($ Millions)
Figure 38. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 39. Americas Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 40. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 41. Americas Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 42. United States Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 43. Canada Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 44. Mexico Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 45. Brazil Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 46. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Region in 2022
Figure 47. APAC Radiopharmaceutical (Oral Route) Revenue Market Share by Regions in 2022
Figure 48. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 49. APAC Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 50. China Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 51. Japan Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 52. South Korea Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 53. Southeast Asia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 54. India Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Australia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 56. China Taiwan Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 57. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 58. Europe Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 59. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 60. Europe Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 61. Germany Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 62. France Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 63. UK Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 64. Italy Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 65. Russia Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 66. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Country in 2022
Figure 67. Middle East & Africa Radiopharmaceutical (Oral Route) Revenue Market Share by Country in 2022
Figure 68. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Type (2018-2023)
Figure 69. Middle East & Africa Radiopharmaceutical (Oral Route) Sales Market Share by Application (2018-2023)
Figure 70. Egypt Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 71. South Africa Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 72. Israel Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 73. Turkey Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 74. GCC Country Radiopharmaceutical (Oral Route) Revenue Growth 2018-2023 ($ Millions)
Figure 75. Manufacturing Cost Structure Analysis of Radiopharmaceutical (Oral Route) in 2022
Figure 76. Manufacturing Process Analysis of Radiopharmaceutical (Oral Route)
Figure 77. Industry Chain Structure of Radiopharmaceutical (Oral Route)
Figure 78. Channels of Distribution
Figure 79. Global Radiopharmaceutical (Oral Route) Sales Market Forecast by Region (2024-2029)
Figure 80. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Region (2024-2029)
Figure 81. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Type (2024-2029)
Figure 82. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Type (2024-2029)
Figure 83. Global Radiopharmaceutical (Oral Route) Sales Market Share Forecast by Application (2024-2029)
Figure 84. Global Radiopharmaceutical (Oral Route) Revenue Market Share Forecast by Application (2024-2029)
